Literature DB >> 26108355

AMPKα2 reduces renal epithelial transdifferentiation and inflammation after injury through interaction with CK2β.

Shulan Qiu1,2,3, Zhicheng Xiao1,2,3, Chunmei Piao1,2,3, Jing Zhang1,2,3, Yanjun Dong1,2,3, Wei Cui1,2,3, Xin Liu4, Youyi Zhang5, Jie Du1,2,3.   

Abstract

TGFβ1/Smad, Wnt/β-catenin and snail1 are preferentially activated in renal tubular epithelia after injury, leading to epithelial-mesenchymal transition (EMT). The stress response is coupled to EMT and kidney injury; however, the underlying mechanism of the stress response in EMT remains elusive. AMP-activated protein kinase (AMPK) signalling is responsive to stress and regulates cell energy balance and differentiation. We found that knockdown of AMPKα, especially AMPKα2, enhanced EMT by up-regulating β-catenin and Smad3 in vitro. AMPKα2 deficiency enhanced EMT and fibrosis in a murine unilateral ureteral obstruction (UUO) model. AMPKα2 deficiency also increased the expression of chemokines KC and MCP-1, along with enhanced infiltration of inflammatory cells into the kidney after UUO. CK2β interacted physically with AMPKα and enhanced AMPKα Thr172 phosphorylation and its catalytic activity. Thus, activated AMPKα signalling suppresses EMT and secretion of chemokines in renal tubular epithelia through interaction with CK2β to attenuate renal injury.
Copyright © 2015 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Keywords:  AMPKα2; CK2β; EMT; fibrosis; renal inflammation

Mesh:

Substances:

Year:  2015        PMID: 26108355     DOI: 10.1002/path.4579

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  10 in total

Review 1.  Metabolic reprogramming and tolerance during sepsis-induced AKI.

Authors:  Hernando Gómez; John A Kellum; Claudio Ronco
Journal:  Nat Rev Nephrol       Date:  2017-01-16       Impact factor: 28.314

2.  Absence of the β1 subunit of AMP-activated protein kinase reduces myofibroblast infiltration of the kidneys in early diabetes.

Authors:  Suet-Wan Choy; Scott A Fraser; Marina Katerelos; Sandra Galic; Bruce E Kemp; Peter F Mount; David A Power
Journal:  Int J Exp Pathol       Date:  2019-04-26       Impact factor: 1.925

Review 3.  Functional characterization of AMP-activated protein kinase signaling in tumorigenesis.

Authors:  Ji Cheng; Tao Zhang; Hongbin Ji; Kaixiong Tao; Jianping Guo; Wenyi Wei
Journal:  Biochim Biophys Acta       Date:  2016-09-25

4.  Suppressive effect of AMP-activated protein kinase on the epithelial-mesenchymal transition in retinal pigment epithelial cells.

Authors:  Ryo Matoba; Yuki Morizane; Yusuke Shiode; Masayuki Hirano; Shinichiro Doi; Shinji Toshima; Ryoichi Araki; Mika Hosogi; Tomoko Yonezawa; Fumio Shiraga
Journal:  PLoS One       Date:  2017-07-18       Impact factor: 3.240

5.  Effects of Qingshen Granules on the Oxidative Stress-NF/kB Signal Pathway in Unilateral Ureteral Obstruction Rats.

Authors:  Hua Jin; Yiping Wang; Dong Wang; Lei Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2018-02-08       Impact factor: 2.629

6.  1,25-(OH)2D3 ameliorates renal interstitial fibrosis in UUO rats through the AMPKα/mTOR pathway.

Authors:  Shasha Tian; Xiaopeng Yang; Jianwu Wang; Jing Luo; Hui Guo
Journal:  J Int Med Res       Date:  2021-02       Impact factor: 1.671

7.  Whole genome sequence analyses of eGFR in 23,732 people representing multiple ancestries in the NHLBI trans-omics for precision medicine (TOPMed) consortium.

Authors:  Bridget M Lin; Kelsey E Grinde; Jennifer A Brody; Charles E Breeze; Laura M Raffield; Josyf C Mychaleckyj; Timothy A Thornton; James A Perry; Leslie J Baier; Lisa de Las Fuentes; Xiuqing Guo; Benjamin D Heavner; Robert L Hanson; Yi-Jen Hung; Huijun Qian; Chao A Hsiung; Shih-Jen Hwang; Margaret R Irvin; Deepti Jain; Tanika N Kelly; Sayuko Kobes; Leslie Lange; James P Lash; Yun Li; Xiaoming Liu; Xuenan Mi; Solomon K Musani; George J Papanicolaou; Afshin Parsa; Alex P Reiner; Shabnam Salimi; Wayne H-H Sheu; Alan R Shuldiner; Kent D Taylor; Albert V Smith; Jennifer A Smith; Adrienne Tin; Dhananjay Vaidya; Robert B Wallace; Kenichi Yamamoto; Saori Sakaue; Koichi Matsuda; Yoichiro Kamatani; Yukihide Momozawa; Lisa R Yanek; Betsi A Young; Wei Zhao; Yukinori Okada; Gonzalo Abecasis; Bruce M Psaty; Donna K Arnett; Eric Boerwinkle; Jianwen Cai; Ida Yii-Der Chen; Adolfo Correa; L Adrienne Cupples; Jiang He; Sharon Lr Kardia; Charles Kooperberg; Rasika A Mathias; Braxton D Mitchell; Deborah A Nickerson; Steve T Turner; Vasan S Ramachandran; Jerome I Rotter; Daniel Levy; Holly J Kramer; Anna Köttgen; Stephen S Rich; Dan-Yu Lin; Sharon R Browning; Nora Franceschini
Journal:  EBioMedicine       Date:  2021-01-05       Impact factor: 8.143

Review 8.  Emerging Therapeutic Strategies for Attenuating Tubular EMT and Kidney Fibrosis by Targeting Wnt/β-Catenin Signaling.

Authors:  Lichao Hu; Mengyuan Ding; Weichun He
Journal:  Front Pharmacol       Date:  2022-01-10       Impact factor: 5.810

9.  NANOG regulates epithelial-mesenchymal transition via AMPK/mTOR signalling pathway in ovarian cancer SKOV-3 and A2780 cells.

Authors:  Hee Yun; Gwan Hee Han; Julie Kim; Joon-Yong Chung; Jae-Hoon Kim; Hanbyoul Cho
Journal:  J Cell Mol Med       Date:  2022-09-16       Impact factor: 5.295

10.  Knockdown of AMPKα2 impairs epithelial‑mesenchymal transition in rat renal tubular epithelial cells by downregulating ETS1 and RPS6KA1.

Authors:  Xiaoming Yin; Fujiang Ma; Xu Fan; Qi Zhao; Xin Liu; Yi Yang
Journal:  Mol Med Rep       Date:  2020-10-01       Impact factor: 2.952

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.